Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-12 Option Award |
2024-12-13 4:15 pm |
N/A 2034-12-11 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:24 pm |
N/A 2034-06-03 |
PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director |
3,902 | $0 | 13,549 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:14 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:06 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:48 pm |
N/A 2033-06-14 |
PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director |
7,576 | $0 | 14,512 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:12 pm |
N/A 2032-08-10 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:13 pm |
N/A N/A |
PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director |
2,001 | $37.48 | 11,141 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:13 pm |
N/A 2032-06-06 |
PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director |
4,205 | $0 | 11,141 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 5:37 pm |
N/A 2032-06-02 |
Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-05-13 Equity Swap |
2022-05-16 6:39 pm |
N/A 2031-04-04 |
Intersect ENT Inc. | XENT | Sandoval Elisabeth Director |
15,896 | $28.25 | 0 (Direct) |
View |
| 2021-10-21 Option Award |
2021-10-25 7:31 pm |
N/A N/A |
PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director |
4,935 | $40.46 | 4,935 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 5:06 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2021-04-05 Option Award |
2021-04-07 6:18 pm |
N/A 2031-04-04 |
Intersect ENT Inc. | XENT | Sandoval Elisabeth Director |
15,896 | $0 | 15,896 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 6:04 pm |
N/A 2030-12-03 |
Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 4:39 pm |
N/A 2030-08-03 |
Menlo Therapeutics Inc. | MNLO | Sandoval Elisabeth Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 7:25 pm |
N/A 2030-06-11 |
Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director |
10,000 | $0 | 10,000 (Direct) |
View |